• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Novartis recalls Sandimmune oral solution due to crystal formation

cafead

Administrator
Staff member
  • cafead   Sep 12, 2023 at 07:22: PM
via Novartis has announced a voluntary recall of one lot of its 100mg/mL Sandimmune Oral Solution (cyclosporine oral solution, USP) in the US due to crystal formation that was observed in some bottles.

article source